LAG-3 inhibitors: A new type of immunotherapy
Immunotherapy harnesses the natural power of the immune system and enhances its response to cancer. Immune checkpoint inhibitors are the most commonly used type of immunotherapy. There are several types, and they all work by interfering with mechanisms on a cancer cell or on a type of immune cell called T cells.
Recently, a new type of immune checkpoint inhibitor called a LAG-3 inhibitor was approved by the Food and Drug Administration...
RET inhibitors: A treatment for any RET-altered cancer
Cancer research is advancing rapidly, and patients are benefitting from new therapies faster than ever. One example is a type of targeted...